Compound Detail
CHEMBL3780819
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3780819 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PAKOONUBMFWMHZ-QHCPKHFHSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
386.4
MW (Da)
5.29
ALogP
4
HBA
0
HBD
44.1
PSA (Ų)
0.42
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Trypanosoma cruzi | IC50 | = | 1800.0 | nM | 5.75 | Antiparasitic activity against nifurtimox-sensitive amastigote stage of Trypanos... | 26922226 |
| Plasmodium falciparum | IC50 | = | 2300.0 | nM | 5.64 | Antiparasitic activity against chloroquine-resistant erythrocytic stage of Plasm... | 26922226 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26922226 | 10.1016/j.ejmech.2016.02.028 | Trypanosoma cruzi | 1 |
| 26922226 | 10.1016/j.ejmech.2016.02.028 | Leishmania infantum | 1 |
| 26922226 | 10.1016/j.ejmech.2016.02.028 | Trypanosoma brucei rhodesiense | 1 |
| 26922226 | 10.1016/j.ejmech.2016.02.028 | Plasmodium falciparum | 1 |
| 26922226 | 10.1016/j.ejmech.2016.02.028 | MRC5 | 1 |
| 26922226 | 10.1016/j.ejmech.2016.02.028 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine